Finerenone in Type 1 Diabetes and Chronic Kidney Disease

Journal:

The New England Journal of Medicine

Published:

2026-03-05

DOI:

10.1056/nejmoa2512854

Affiliations:

24

Authors:

19

Go to article

Institutions	Authors	Share
Bayer, Germany	4.000000	0.21
University Medical Center Groningen (UMCG), RUG, Netherlands	1.333333	0.07
Toronto General Hospital (TGH), U of T, Canada	1.000000	0.05
Catholic University of Leuven (KU Leuven), Belgium	1.000000	0.05
Harvard Joslin Diabetes Center, United States of America (USA)	1.000000	0.05
AdventHealth, United States of America (USA)	1.000000	0.05
Bayer Plc, United Kingdom (UK)	1.000000	0.05
HUS Helsinki University Hospital, Finland	1.000000	0.05
Washington University in St. Louis (WUSTL), United States of America (USA)	1.000000	0.05
Peking University People's Hospital, PKUHSC, China	1.000000	0.05
The University of Edinburgh, United Kingdom (UK)	1.000000	0.05
University of Miami (UM), United States of America (USA)	1.000000	0.05
Steno Diabetes Center Copenhagen (SDCC), Denmark	0.500000	0.03
Providence Inland Northwest Health Services (INHS), United States of America (USA)	0.500000	0.03
University of Washington (UW), United States of America (USA)	0.500000	0.03
University of Copenhagen (UCPH), Denmark	0.500000	0.03
Institute for Diabetes Research and Metabolic Diseases (IDM), Germany	0.333333	0.02
German Center for Diabetes Research (DZD), Germany	0.333333	0.02
University of Tübingen (Uni Tübingen), Germany	0.333333	0.02
The George Institute for Global Health (TGI), Australia	0.333333	0.02
University of New South Wales (UNSW Sydney), Australia	0.333333	0.02

Interested in Clinical Sciences?